Focus: Cala Health is an early-stage neurology-focused biotech company developing neuromodulation devices for conditions like essential tremor and neurological indications. Founded in 2019 and headquartered in San Mateo, CA, the company operates at pre-revenue/clinical stage with a specialized device portfolio.
Profile data last refreshed 23m ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
4 added, 3 removed. Backfill posture.
Best suited for early-career professionals or those seeking device-driven neurology experience, but require strong due diligence on funding runway and clinical progress before committing.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cala Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Cala Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo